protein

Recombinant Diazepam Binding Inhibitor (DBI)

MBS2010619

0.01 mg

150 USD

Recombinant Protein

Recombinant Diazepam Binding Inhibitor (DBI)

[Diazepam Binding Inhibitor (DBI)]

[acyl-CoA-binding protein isoform 2; Acyl-CoA-binding protein; acyl-CoA-binding protein; acyl-CoA binding protein; diazepam-binding inhibitor; diazepam binding inhibitor, splice form 1b; diazepam binding inhibitor; Diazepam-binding inhibitor; DBI; Endozepine]

[DBI]

[Dbi; Dbi; EP; Acbp; ACBD1; endozepine; ACBP; DBI; EP]

ACBP_MOUSE

E Coli

SQAEFDKAA EEVKRLKTQP TDEEMMLFIYS HFKQATVGDV NTDRPGLLDL KGKAKWDSWN KLKGTSKESA MKTYVEKVDE LKKKYGI

> 95%

Supplied as lyophilized form in PBS,pH7.4, containing 5% sucrose, 0.01% sarcosyl.

Original Concentration: 200 Ug/mL

Storage: Avoid repeated freeze/thaw cycles. Store at 2-8ºC for one month. Aliquot and store at -80ºC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Positive Control; Immunogen; SDS-PAGE; WB. (May be suitable for use in other assays to be determined by the end user.)

SDS-Page

Organism Species: Mus musculus. Source: Prokaryotic expression. Residues: Ser2~Ile87. Tags: N-terminal His Tag. Traits: Freeze-dried powder. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose and Proclin300. USAGE: Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex. Subcellular Location: Endoplasmic reticulum lumen

Predicted isoelectric point: 8.0. Predicted Molecular Mass: 11.1kDa. Accurate Molecular Mass: 13kDa as determined by SDS-PAGE reducing conditions.

6681137

NP_031856.1

NM_007830.4

P31786

PPAR (Peroxisome Proliferator-activated Receptor) Signaling Pathway (522983); PPAR Signaling Pathway (83239); PPAR Signaling Pathway (694605); PPAR Signaling Pathway (450)

DBI: Binds medium- and long-chain acyl-CoA esters with very high affinity and may function as an intracellular carrier of acyl-CoA esters. It is also able to displace diazepam from the benzodiazepine (BZD) recognition site located on the GABA type A receptor. It is therefore possible that this protein also acts as a neuropeptide to modulate the action of the GABA receptor. Belongs to the ACBP family. 6 isoforms of the human protein are produced by alternative promoter. Protein type: Lipid-binding. Cellular Component: Golgi apparatus; extracellular space; synaptic vesicle; contractile fiber; mitochondrion; endoplasmic reticulum; cytoplasm; plasma membrane; nucleus. Molecular Function: protein dimerization activity; benzodiazepine receptor binding; acyl-CoA binding; lipid binding. Biological Process: glial cell proliferation; skin development; behavioral fear response; triacylglycerol metabolic process; negative regulation of fatty acid beta-oxidation; learning and/or memory; hair follicle development; transport; positive regulation of release of sequestered calcium ion into cytosol; positive regulation of lipid biosynthetic process; lateral ventricle development; regulation of synaptic transmission, GABAergic

0.01 mg

150 USD

0.05 mg

290

0.1 mg

455

0.2 mg

560

0.5 mg

1080

1 mg

1610